How Much Did Alexso Raise?
Funding & Key Investors

Alexso, a prominent player in the pharmaceutical wholesale sector, has successfully secured a major strategic investment, bringing its total capital accumulation to $352K. This latest infusion of $202K underscores the company's robust market position and its ongoing commitment to scaling operations within the specialized non-opioid pain management landscape. By leveraging this recent financing, the firm is well-positioned to accelerate its growth trajectory and solidify its influence in the healthcare supply chain.

What is Alexso?

Alexso
RetailDrug Stores & Pharmacies

Founded in 2010 and headquartered in Los Angeles, Alexso Inc. operates as a critical intermediary in the pharmaceutical distribution ecosystem. The company distinguishes itself through a specialized focus on non-opioid pain management solutions, addressing a vital need for clinically tested alternatives in the medical community. Serving a diverse clientele that includes hospitals, physicians, retail pharmacies, and fellow wholesalers, Alexso has cultivated a reputation for operational excellence and product reliability. Its business model is anchored in the provision of high-quality therapeutic products that prioritize patient well-being while navigating the complex regulatory environment of the pharmaceutical industry. As a privately held entity, Alexso has demonstrated consistent performance, effectively capturing niche market segments and establishing a scalable infrastructure that supports its long-term strategic objectives.

How much funding has Alexso raised?

Alexso has raised a total of $352K across 2 funding rounds:

2020

Debt

$150K

2021

Debt

$202K

Debt (2020): $150K with participation from PPP

Debt (2021): $202K led by PPP

Key Investors in Alexso

PPP

Public-Private Partnership

What's next for Alexso?

With the successful completion of this late-stage funding round, Alexso is poised to transition into a phase of aggressive international expansion. The strategic deployment of this capital will likely focus on enhancing supply chain efficiencies, broadening the distribution network, and investing in the clinical validation of new pain management offerings. By fostering deeper partnerships across the healthcare continuum, the company aims to mitigate the reliance on traditional pain relief methods and establish itself as a global leader in non-opioid therapeutic distribution. The management team is expected to prioritize market penetration in emerging regions, ensuring that their specialized portfolio reaches a wider demographic of healthcare providers and patients, thereby driving sustainable long-term value for stakeholders.

See full Alexso company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Retail industry

Grocery RetailRetail
Home Improvement & Hardware RetailRetail
Automobile DealersRetailAutomotive Service & Collision RepairConsumer Services
Office Products Retail & DistributionRetailIndustrial Machinery & EquipmentManufacturingOther Rental Stores (Furniture, A/V, Construction & Industrial Equipment)

Frequently Asked Questions Regarding Alexso Financial Insights

What are the most recent funding rounds that Alexso has completed, and what were the funding rounds?
Alexso has recently completed 2 funding rounds: Debt on Feb 5, 2021, Debt on May 2, 2020.
What is the total amount of funding Alexso has raised to date?
Alexso has raised a total of $352K in funding to date.
How many funding rounds has Alexso completed?
Alexso has completed 2 funding rounds.
How much funding did Alexso raise in its most recent funding round?
Alexso raised $202K in its most recent funding round.
Who are the lead investors in Alexso's latest funding round?
The lead investor in Alexso's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Alexso's history?
The largest funding round in Alexso's history was $202K.
See more information about Alexso